Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PE(36:3e)/PE(36:2p) | Lipid-depleted/compactin | 0.0 | BCD100322A02 | 186 | pmol/sample |
| - | PE(36:3e)/PE(36:2p) | Lipid-depleted/compactin | 0.5 | BCD100322A05 | 269 | pmol/sample |
| - | PE(36:3e)/PE(36:2p) | Lipid-depleted/compactin | 1.0 | BCD100322A09 | 260 | pmol/sample |
| - | PE(36:3e)/PE(36:2p) | Lipid-depleted/compactin | 2.0 | BCD100322A13 | 69.3 | pmol/sample |
| - | PE(36:3e)/PE(36:2p) | Lipid-depleted/compactin | 4.0 | BCD100322A17 | 75.5 | pmol/sample |
| - | PE(36:3e)/PE(36:2p) | Lipid-depleted/compactin | 8.0 | BCD100322A21 | 80.1 | pmol/sample |
| - | PE(36:3e)/PE(36:2p) | Lipid-depleted/compactin | 12.0 | BCD100322A25 | 361 | pmol/sample |
| - | PE(36:3e)/PE(36:2p) | Lipid-depleted/compactin | 24.0 | BCD100322A29 | 431 | pmol/sample |
| - | PE(36:3e)/PE(36:2p) | C | 0.0 | BCD100322A01 | 123 | pmol/sample |
| - | PE(36:3e)/PE(36:2p) | C | 0.5 | BCD100322A03 | 251 | pmol/sample |
| - | PE(36:3e)/PE(36:2p) | C | 1.0 | BCD100322A07 | 271 | pmol/sample |
| - | PE(36:3e)/PE(36:2p) | C | 2.0 | BCD100322A11 | 345 | pmol/sample |
| - | PE(36:3e)/PE(36:2p) | C | 4.0 | BCD100322A15 | 59.8 | pmol/sample |
| - | PE(36:3e)/PE(36:2p) | C | 8.0 | BCD100322A19 | 66.7 | pmol/sample |
| - | PE(36:3e)/PE(36:2p) | C | 12.0 | BCD100322A23 | 76.1 | pmol/sample |
| - | PE(36:3e)/PE(36:2p) | C | 24.0 | BCD100322A27 | 322 | pmol/sample |
| - | PE(36:3e)/PE(36:2p) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | 305 | pmol/sample |
| - | PE(36:3e)/PE(36:2p) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 356 | pmol/sample |
| - | PE(36:3e)/PE(36:2p) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | 215 | pmol/sample |
| - | PE(36:3e)/PE(36:2p) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | 79.9 | pmol/sample |
| - | PE(36:3e)/PE(36:2p) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | 85 | pmol/sample |
| - | PE(36:3e)/PE(36:2p) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | 406 | pmol/sample |
| - | PE(36:3e)/PE(36:2p) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | 497 | pmol/sample |
| - | PE(36:3e)/PE(36:2p) | 25OH-Chol | 0.5 | BCD100322A04 | 234 | pmol/sample |
| - | PE(36:3e)/PE(36:2p) | 25OH-Chol | 1.0 | BCD100322A08 | 341 | pmol/sample |
| - | PE(36:3e)/PE(36:2p) | 25OH-Chol | 2.0 | BCD100322A12 | 91.7 | pmol/sample |
| - | PE(36:3e)/PE(36:2p) | 25OH-Chol | 4.0 | BCD100322A16 | 77.9 | pmol/sample |
| - | PE(36:3e)/PE(36:2p) | 25OH-Chol | 8.0 | BCD100322A20 | 67.3 | pmol/sample |
| - | PE(36:3e)/PE(36:2p) | 25OH-Chol | 12.0 | BCD100322A24 | 70.9 | pmol/sample |
| - | PE(36:3e)/PE(36:2p) | 25OH-Chol | 24.0 | BCD100322A28 | 388 | pmol/sample |